The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 19, 2022
Filed:
Dec. 21, 2018
Applicant:
Musculoskeletal Transplant Foundation, Edison, NJ (US);
Inventors:
Eric Semler, Morganville, NJ (US);
Alex Callahan, Edison, NJ (US);
Joed Canales, Harrison, NJ (US);
Katrina Carroll, Jacobstown, NJ (US);
Anouska Dasgupta, North Brunswick, NJ (US);
Roman Shikanovich, Edison, NJ (US);
Assignee:
Musculoskeletal Transplant Foundatiaon, Edison, NJ (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/32 (2006.01); A61L 27/36 (2006.01); A61K 35/32 (2015.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); C12N 5/073 (2010.01); C12N 5/0775 (2010.01); A61L 27/38 (2006.01); A61L 27/00 (2006.01); C12N 5/077 (2010.01); A61L 27/40 (2006.01); A61L 27/54 (2006.01); A61K 35/50 (2015.01); A61K 35/35 (2015.01);
U.S. Cl.
CPC ...
A61L 27/3608 (2013.01); A61K 35/32 (2013.01); A61K 38/18 (2013.01); A61K 38/1825 (2013.01); A61K 38/1841 (2013.01); A61K 38/19 (2013.01); A61L 27/00 (2013.01); A61L 27/3683 (2013.01); A61L 27/3821 (2013.01); A61L 27/3847 (2013.01); A61L 27/40 (2013.01); A61L 27/54 (2013.01); C12N 5/0605 (2013.01); C12N 5/0654 (2013.01); C12N 5/0667 (2013.01); C12N 5/0668 (2013.01); A61K 35/35 (2013.01); A61K 35/50 (2013.01); A61L 2300/414 (2013.01); A61L 2300/64 (2013.01); A61L 2430/02 (2013.01); C12N 2533/90 (2013.01);
Abstract
The disclosure provides implants containing a plurality of particles containing at least one population of viable cells adherent to and resident in soft tissue matrix or at least one viable population of cells caused to be in contact with the soft tissue matrix; methods of fabricating the implants; and use of the implants in tissue repair.